WI
BBH icon

WBI Investments’s VanEck Biotech ETF BBH Stock Holding History

WBI Investments’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-20,934
Closed -$2.61M – 196
2017
Q4 		$2.61M Buy
+20,934
New +$2.67M 0.12% 126

Other funds holding BBH

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
BRM
Boston Research & Management Manchester, Massachusetts $421M AUM 16.18% 1-Year Est. Return

WBI Investments's BBH Position: Q1 2018 in Review

WBI Investments sold out of VanEck Biotech ETF (BBH) in Q1 2018, closing a stake of 20,934 shares — an estimated $2.61M sold.

WBI Investments first reported a position in BBH in Q4 2017 and held it in 1 quarter. The position peaked at $2.61M in Q4 2017. 82 funds tracked by Wall St. Rank hold BBH as of Q1 2018.

  • WBI Investments reported no remaining VanEck Biotech ETF position as of Q1 2018 after selling out during the quarter.
  • WBI Investments sold 20,934 VanEck Biotech ETF shares in Q1 2018, an estimated $2.61M.
  • WBI Investments first reported a position in VanEck Biotech ETF in Q4 2017 and held it in 1 quarter.
  • WBI Investments's VanEck Biotech ETF position peaked at $2.61M in Q4 2017.
  • 82 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2018.

Based on WBI Investments's 13F filing for Q1 2018, filed 10 May 2018.